4.6 Review

Thalidomide in the treatment of leprosy

Journal

MICROBES AND INFECTION
Volume 4, Issue 11, Pages 1193-1202

Publisher

ELSEVIER
DOI: 10.1016/S1286-4579(02)01645-3

Keywords

thalidomide; leprosy; erythema nodosum leprosum; type 2 reaction

Ask authors/readers for more resources

Leprosy is a chronic infection of the skin and nerves caused by Mycobacterium leprae. Erythema nodosum leprosum (ENL) is a reactive state in lepromatous leprosy. Thalidomide has been used to treat ENL since the 1960s. One of its mechanisms of action is anti-inflammatory through selective inhibition of the pro-inflammatory cytokine TNF-alpha produced by monocytes. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available